0
43

Contract Development and Manufacturing Organization Market to Reach $278.98 Billion by 2026

The global “contract development and manufacturing organization market” size is projected to reach USD 278.98 billion by the end of 2026. Mergers and acquisitions are a growing trend among major companies across the world. According to a report published by Fortune Business Insights, titled “Contract Development and Manufacturing Organization (CDMO) Market Size, Share & Industry Analysis, By Service {By CMO (API, Finished Product {Solid Dosage Forms, Injectables, and Others}, and Packaging)} {By CRO (Discovery, Preclinical, Clinical Trial, and Laboratory Services)} and Regional Forecast, 2019-2026,” the market was worth USD 130.80 billion in 2018 and will exhibit a CAGR of 10.0% during the forecast period, 2019-2026.

Request a Sample Copy of the Research Report

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/contract-development-and-manufacturing-organization-cdmo-outsourcing-market-102502

Report Overview:

The contract development and manufacturing organization market is segmented on the basis of factors such as service and geographies. The report provides forecast values for the market for the period of 2019-2026. The factual figures have been obtained through trusted sources. Moreover, these predictions are made on the basis of extensive research analysis methods, coupled with the opinions of experienced market research professionals. The report highlights the latest product launches and labels major innovations in the market. In addition to this, it states the impact of these products on the growth of the market. The competitive landscape has been discussed in detail and predictions are made with respect to leading companies and products in the coming years.

Click here to get the short-term and long-term impact of COVID-19 on this Market.

Please visit: https://www.fortunebusinessinsights.com/contract-development-and-manufacturing-organization-cdmo-outsourcing-market-102502

Product Overview:

A contract development and manufacturing organization (CDMO) helps healthcare companies for the development of drugs. It is involved in the overall process, right from the clinical trials till the commercialization and distribution of the drugs. The complexities in therapies and lack of in-house manufacturing capabilities will have a positive impact on the growth of the market in the coming years. The high investment in CDMOs will bode well for the overall market in the coming years. Moreover, the increasing number of strategic mergers and collaborations will contribute to the growth of the market. The use of advanced technologies in drug development processes will emerge in favor of the companies operating in the market.

List of companies profiled in the report:

  • Catalent, Inc
  • Baxter
  • Vetter
  • Recipharm AB
  • Albany Molecular Research Inc. (AMRI)
  • Thermo Fisher Scientific Inc. (Patheon)
  • Unither
  • DPT LABORATORIES LTD.
  • NextPharma Technologies
  • Others

Industry Developments:

February 2019: Jubilant Biosys collaborated with Sanofi to develop small molecule inhibitors for in the CNS therapeutic area.

LEAVE A REPLY

Please enter your comment!
Please enter your name here